DUBLIN, Calif., July 26 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2007 second quarter financial results on Thursday, August 2, 2007. SuperGen Management will provide details on the Company’s 2007 second quarter financial results, and any revised outlook for the future.
A press release will be transmitted to the news media immediately following the close of the market on August 2nd. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast is accessible via the investor relations section of the Company’s Web site at www.supergen.com. A webcast replay of the conference call will be available for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen SuperGen Timothy L. Enns Mary M. Vegh S.V.P., Corporate Communications Manager, Investor Relations & Business Development (925) 560-2845 (925) 560-0100, x111 mary.vegh@supergen.comtenns@supergen.com
SuperGen Inc.
CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, +1-925-560-0100, Ext. 111, tenns@supergen.com, or Mary M.Vegh, Manager, Investor Relations, +1-925-560-2845, mary.vegh@supergen.com,both of SuperGen Inc.
Web site: http://www.supergen.com//
